BIOHK2025-Human-Microbial Pathway Interplay in Metabolic Diseases and Treatment

Related content

• Research Output

• Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome

  Research output: Contribution to journal › Journal article › peer-review

• Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis

  Research output: Contribution to journal › Journal article › peer-review

• Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptor

  Research output: Contribution to journal › Journal article › peer-review

• Early life stress disrupts intestinal homeostasis via NGF-TrkA signaling

  Research output: Contribution to journal › Journal article › peer-review

• Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2

  Research output: Contribution to journal › Journal article › peer-review

• The carotenoid torularhodin alleviates NAFLD by promoting Akkermanisa muniniphila-mediated adenosylcobalamin metabolism

  Research output: Contribution to journal › Journal article › peer-review

• Body weight regulation via MT1-MMP-mediated cleavage of GFRAL

  Research output: Contribution to journal › Journal article › peer-review

• Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis

  Research output: Contribution to journal › Journal article › peer-review

• MT1-MMP inhibition rejuvenates ageing brain and rescues cognitive deficits in obesity

  Research output: Contribution to journal › Journal article › peer-review

• Prizes / Awards

• NSFC Excellent Young Scientists Fund (Hong Kong and Macao)

  Prize: Award